Drug archive
Pemirolast (Ophthalmic)Before Using
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Before Using This Medicine
In deciding to use a medicine, the risks of using the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For pemirolast, the following should be considered:
Allergies - Tell your doctor if you have ever had any unusual or allergic reaction to pemirolast. Also tell your doctor and pharmacist if you are allergic to any other substances, such as [foods, preservatives, or dyes].
Pregnancy - Pemirolast has not been shown to cause birth defects or other problems in humans. However, in rats given 20,000 to 30,000 times the human dose of pemirolast, there was an increase in the number of fetal bone and heart deformities as well as an increased number of fetal implantation losses.
Breast-feeding - It is not known whether pemirolast passes into human breast milk. Although most medicines pass into breast milk in small amounts, many of them may be used safely while breast feeding. Mothers who are taking this medicine and who wish to breast-feed should discuss this with their doctor.
Children - This medicine has been tested in children 3 years of age and older and, in effective doses, has not been shown to cause different side effects or problems than it does in adults.
Older adults - There is no specific information available comparing the use of pemirolast in the elderly with use in other age groups.
Other medical problems - The presence of other medical problems may affect the use of pemirolast. Make sure you tell your doctor if you have any other medical problems, especially:
- Contact lens-related irritation - Pemirolast should not be used to treat this condition